MedTrace Logo

MultiPoint Pacing™ Post Market Study

NCT02832622 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2169

Last updated 2021-02-17

Study results available
· View outcomes & findings →

Summary

This is a prospective, multicenter, non-randomized registry/observational study. The study will enroll up to 2,000 patients with successful St. Jude Medical (SJM) Cardiac Resynchronization Therapy (CRT) MP device implant from up to 140 centers undergoing CRT implantation.

Conditions

Interventions

DEVICE

MPP

MPP ON within 1 month post implant and then continuously programmed ON until 12 months (i.e., MPP ON for months 1-12 continuously)

DEVICE

BiV/MPP

MPP ON at the 12-month study visit and for at least 3 continuous months prior to 12-month assessment (i.e., BiV pacing ON at some point in months 1-9 and MPP ON for months 10-12)

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Clay Cohorn · Abbott Medical Devices

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2019-07-15
Completion
2019-07-15

Countries

  • United States
  • Argentina
  • Colombia
  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02832622 on ClinicalTrials.gov